Pathway mapping reveals antiretroviral treatments' targeted cell cycle regulation in lung cancer

dc.contributor.authorMarima, Rahaba
dc.contributor.authorHull, Rodney
dc.contributor.authorKandhavelu, Jeyalakshmi
dc.contributor.authorDlamini, Zodwa
dc.contributor.authorPenny, Clement
dc.contributor.emailrahaba.marima@up.ac.zaen_ZA
dc.date.accessioned2021-06-11T05:40:56Z
dc.date.available2021-06-11T05:40:56Z
dc.date.issued2020
dc.description.abstractThe human cell cycle is a tightly regulated process with checkpoints in place to ensure genomic integrity. Cyclin/cyclin dependent kinases (CDKs) complexes drive the progression of the cell cycle while CDK-inhibitors (CDKIs) halt the cell cycle. Deregulation of the cell cycle is a hallmark of lung cancer. TP53 and FOXO transcription factors share similar mechanisms in the regulation of the cell cycle. Lung carcinogenesis in the antiretroviral (ARV) era remains to be understood. This study aimed at mapping the biological pathways related to the human cell cycle that are influenced by the ARVs (Efavirenz-EFV and Lopinavir/ritonavir-LPV/r) treatment in A549 and MRC-5 lung cells. For this purpose, Reactome database was used to map these pathways. In addition, the Database for Annotation, Visualisation and Integrated Discovery (DAVID) was used for functional enrichment analysis in a set of genes and to visualise differentially expressed genes within a particular KEGG pathway, and also to perform Gene Ontology. Furthermore, the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database was used to determine the protein-protein interaction of the differentially expressed gene (DEG) targets. Reactome analysis revealed a decrease in DNA replication and an increase in response to external stimuli and DNA repair genes in both normal and adenocarcinoma lung cancer models. A further increase in apoptotic genes is observed in the cancer cells in response to ARV treatment. Interestingly, the FOXO pathway was also shown to be upregulated in the test (ARV) groups. KEGG pathway shows a reduction in cyclin/CDK activity in ARV treated models. STRING analysis illustrates a direct and strong interaction between DNA damage and response (DDR) genes upregulated by ARV exposure. Analysis from all three databases suggests the cytotoxic and anti-proliferative effects of EFV and LPV/r on lung cancer.en_ZA
dc.description.departmentInternal Medicineen_ZA
dc.description.librarianhj2021en_ZA
dc.description.sponsorshipThe South African Medical Research Council (SAMRC)en_ZA
dc.description.urihttps://http//www.elsevier.com/locate/imuen_ZA
dc.identifier.citationMarima, R., Hull, R., Kandhavelu, J. et al. 2020, 'Pathway mapping reveals antiretroviral treatments' targeted cell cycle regulation in lung cancer', Informatics in Medicine Unlocked, vol. 21, art. 100426, pp. 1-10.en_ZA
dc.identifier.issn2352-9148
dc.identifier.other10.1016/j.imu.2020.100426
dc.identifier.urihttp://hdl.handle.net/2263/80276
dc.language.isoenen_ZA
dc.publisherElsevieren_ZA
dc.rights© 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.en_ZA
dc.subjectCell cycleen_ZA
dc.subjectBioinformaticsen_ZA
dc.subjectp53en_ZA
dc.subjectFOXOen_ZA
dc.subjectCyclin dependent kinases (CDKs)en_ZA
dc.subjectAntiretroviral (ARV)en_ZA
dc.subjectCell cycle regulationen_ZA
dc.titlePathway mapping reveals antiretroviral treatments' targeted cell cycle regulation in lung canceren_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Marima_Pathway_2020.pdf
Size:
9.53 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: